Medifast Inc
MED13.640USD
-0.110-0.80%
Market hours （ET）Quotes delayed by 15 min
149.92MMarket Cap
LossP/E TTM
More Details of Medifast Inc Company
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Company Info
Ticker SymbolMED
Company nameMedifast Inc
IPO dateDec 30, 1993
CEOMr. Daniel R. (Dan) Chard
Number of employees504
Security typeOrdinary Share
Fiscal year-endDec 30
Address100 International Drive, 18th Floor
CityBALTIMORE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code21202
Phone14105818042
Websitehttps://medifastinc.com/
Ticker SymbolMED
IPO dateDec 30, 1993
CEOMr. Daniel R. (Dan) Chard
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Revenue Breakdown
FY2025Q1
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
115.73M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, May 29
Updated: Thu, May 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
8.09%
BlackRock Institutional Trust Company, N.A.
7.78%
The Vanguard Group, Inc.
6.95%
Two Sigma Investments, LP
3.96%
Acadian Asset Management LLC
3.51%
Other
69.71%
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
8.09%
BlackRock Institutional Trust Company, N.A.
7.78%
The Vanguard Group, Inc.
6.95%
Two Sigma Investments, LP
3.96%
Acadian Asset Management LLC
3.51%
Other
69.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
29.85%
Investment Advisor/Hedge Fund
22.33%
Hedge Fund
18.63%
Research Firm
3.60%
Individual Investor
3.30%
Family Office
0.70%
Sovereign Wealth Fund
0.65%
Pension Fund
0.19%
Bank and Trust
0.12%
Other
20.62%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
501
8.67M
78.89%
-4.42M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
2023Q1
682
10.76M
99.19%
-441.80K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Renaissance Technologies LLC
888.93K
8.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
855.39K
7.78%
+13.69K
+1.63%
Mar 31, 2025
The Vanguard Group, Inc.
763.56K
6.95%
+15.94K
+2.13%
Mar 31, 2025
Two Sigma Investments, LP
435.72K
3.96%
-12.35K
-2.76%
Mar 31, 2025
Acadian Asset Management LLC
385.72K
3.51%
+113.11K
+41.49%
Mar 31, 2025
D. E. Shaw & Co., L.P.
333.45K
3.03%
+44.66K
+15.47%
Mar 31, 2025
BofA Global Research (US)
288.51K
2.63%
+12.44K
+4.51%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
265.57K
2.42%
+151.43K
+132.68%
Mar 31, 2025
Geode Capital Management, L.L.C.
256.48K
2.33%
+10.55K
+4.29%
Mar 31, 2025
American Century Investment Management, Inc.
224.94K
2.05%
-19.24K
-7.88%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Federated Hermes MDT Small Cap Core ETF
0.27%
First Trust Active Factor Small Cap ETF
0.19%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.14%
Vanguard US Value Factor ETF
0.09%
iShares US Small Cap Value Factor ETF
0.07%
iShares US Small-Cap Equity Factor ETF
0.05%
Schwab Fundamental U.S. Small Company ETF
0.05%
Vanguard US Quality Factor ETF
0.04%
Vanguard US Multifactor ETF
0.03%
iShares Micro-Cap ETF
0.03%
View more
Federated Hermes MDT Small Cap Core ETF
Proportion0.27%
First Trust Active Factor Small Cap ETF
Proportion0.19%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.14%
Vanguard US Value Factor ETF
Proportion0.09%
iShares US Small Cap Value Factor ETF
Proportion0.07%
iShares US Small-Cap Equity Factor ETF
Proportion0.05%
Schwab Fundamental U.S. Small Company ETF
Proportion0.05%
Vanguard US Quality Factor ETF
Proportion0.04%
Vanguard US Multifactor ETF
Proportion0.03%
iShares Micro-Cap ETF
Proportion0.03%
Dividend
A total of
262.40M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
